A Closer Look At Australian And New Zealand Drug Reimbursement Programs
This article was originally published in PharmAsia News
Australia's PBS and New Zealand's PHARMAC draw differing responses from industry.
You may also be interested in...
PERTH, Australia - Australia has the lowest prices for new medicines among developed countries, according to a UK Department of Health report on the Pharmaceutical Price Regulation Scheme
The Australian immuno-therapeutics developer Prima BioMed has had a change of focus in recent months since buying Paris-based Immutep in late 2014. Prima’s lead product used to be its CVac cancer vaccine, but it has now shifted strategic priority to an LAG-3 immune checkpoint receptor that came with the acquisition.
Phylogica is continuing its strong financial year, with the company’s shares surging after it announced that a pilot study for its cell-penetrating peptides (CPPs) showed these were able to kill drug-resistant breast cancer cells in vivo, when linked with the cancer drug Omomyc.